![](/img/cover-not-exists.png)
Characterization of the Novel and Specific PI3K Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
Fritsch, C., Huang, A., Chatenay-Rivauday, C., Schnell, C., Reddy, A., Liu, M., Kauffmann, A., Guthy, D., Erdmann, D., De Pover, A., Furet, P., Gao, H., Ferretti, S., Wang, Y., Trappe, J., Brachmann,Volume:
13
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-13-0865
Date:
May, 2014
File:
PDF, 1014 KB
english, 2014